Royal Marsden NHS Foundation Trust

The Royal Marsden opened its doors in 1851 as the world’s first hospital dedicated to cancer diagnosis, treatment, research and education.

Today it operates as a specialist cancer hospital and National Institute for Health Research (NIHR) Biomedical Research Centre for Cancer, working closely with its principal academic partner, the Institute of Cancer Research (ICR). 

Together, The Royal Marsden and the ICR are ranked in the top five cancer centres in the world for the impact of their research, treating over 59,000 NHS and private patients every year. 

It is a centre of excellence with an international reputation for groundbreaking research and pioneering the very latest in cancer treatments and technologies, as well as specialising in cancer diagnosis and education. 

The Royal Marsden operates from two centres, in Chelsea and Sutton, and they also have a Medical Daycare Unit at Kingston Hospital.  They’re the founder and host of RM Partners, the Cancer Alliance for west London, which includes St George’s Healthcare NHS Foundation Trust, Imperial Healthcare NHS Trust, and other trust and clinical commissioning group (CCG) partners across the north-west and south-west London

HRH The Duke of Cambridge became President of The Royal Marsden in 2007, following a long royal connection with the hospital.

Royal Marsden NHS Foundation Trust and DART

The Royal Marsden NHS Foundation Trust is represented in this partnership by Dr Richard Lee, Consultant Respiratory Physician and Champion for Early Diagnosis at The Royal Marsden, whose role is funded by The Royal Marsden Cancer Charity. Dr Richard Lee is the clinical lead for blood biomarker research within the DART AI programme and is also Joint National Clinical Lead for the NHS England Targeted Lung Health Checks Programme.